Profile
ABCM VRTX VRNA REGN ALNY ARGX
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 1.76K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ABCM VRTX VRNA REGN ALNY ARGX
Quant Rating Score 3 1 4 1 3
Quant Rating Neutral Strong Sell Buy Strong Sell Neutral
Trading
ABCM VRTX VRNA REGN ALNY ARGX
Last Close $23.99 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $23.99 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $23.99 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High 0 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 0 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ABCM VRTX VRNA REGN ALNY ARGX
1 Month Return 0 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 0 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 0 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 0 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 0 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return 0 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Profitability
ABCM VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 71.21 % 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM 0.45 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM 0.76 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM 0.8 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 93.62 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 73.44 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM 2.03 % 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM 27.38 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM 7.04 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM 1.56 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM 195.05 % 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM 31.98 % 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM 0.3 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM 0.01 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 45.81 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM 19.94 % 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM 27.38 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM - 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM 40.46 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM 40.46 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ABCM VRTX VRNA REGN ALNY ARGX
Revenue $0.36B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0.27B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 74.79% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $0.04B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -0.04 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ABCM VRTX VRNA REGN ALNY ARGX
Long Term Debt $0.1B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.33B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.73B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0.22B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $1.06B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ABCM VRTX VRNA REGN ALNY ARGX
Net Income $-0.01B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $-0.01B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $-0.03B $0B $0B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0.04B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.7999
AARD Aardvark Therapeutics, Inc. Common Stock 11.1293
ABCL AbCellera Biologics Inc. 5.445
ABEO Abeona Therapeutics Inc. 5.205
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.2547
ABPWW 0.0143
ABSI Absci Corporation 4.2312
ABUS Arbutus Biopharma Corporation 4.875
ABVC ABVC BioPharma, Inc. 2.84
ABVX Abivax SA American Depositary Shares 104.808
ACAD ACADIA Pharmaceuticals Inc. 22.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7774
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.195
ACIU AC Immune SA 3.465
ACLX Arcellx, Inc. 87.93
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 157.93
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 43.725
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 70.41
MNA IQ Merger Arbitrage ETF 6.85 35.8151
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 93.385
FPXI First Trust International Equity Opportunities ETF 0.45 61.215
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 40.935
MRGR ProShares Merger ETF 3.16608 44.595
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 31.29
VINEX Vanguard International Explorer Fund Investor Shares 0.22 20.53
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 81.31
VGHCX Vanguard Health Care Fund Investor Shares 0.36 192.8
BMED BlackRock Future Health ETF 1.68229 28.4454
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 26.51
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 6.711
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 7.745
DFIC Dimensional International Core Equity 2 ETF 0.00052105 33.125
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 7.724
CTRU ARK Transparency ETF 0.96 12.897
Unlock